ANALYST INTERVIEW: Development in Biotech - Matthew L. Kaplan - Ladenburg Thalmann.

(AAS807) Development in Biotech - Matthew L. Kaplan - Ladenburg Thalmann. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 10/19/09. Tickers featured: AIS, BDSI, BMY, JAV, JNJ, KERX, PFE, TEVA, WYE, XOMA. Complete text approximately 3000 words. Document # AAS807.

ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice [phone]. Fax: [phone]. E-mail: [e-mail].